NASDAQ: BIOL - BIOLASE, Inc.

Yield per half year: -84.5%
Sector: Healthcare

Share chart BIOLASE, Inc.


About

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.

more details
The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, therapy pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

IPO date 1992-11-13
ISIN US0909114052
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0.7874
Дивиденд ао 229.7
Сайт https://www.biolase.com
Цена ао 0.1603
Change price per day: 0% (0.0155)
Change price per week: 0% (0.0155)
Change price per month: 0% (0.0155)
Change price per 3 month: -77% (0.0674)
Change price per half year: -84.5% (0.1)
Change price per year: -98.62% (1.12)
Change price per 3 year: -95.98% (0.3854)
Change price per 5 year: -97.13% (0.5399)
Change price per 10 year: 0% (0.0155)
Change price per year to date: 0% (0.0155)

Underestimation

Title Value Grade
P/S 0.0302 10
P/BV -6 0
P/E 0 0
EV/EBITDA -0.8472 0
Total: 5

Efficiency

Title Value Grade
ROA, % -58.78 0
ROE, % 8353.04 10
Total: 3.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0.6667 6.67
Total: 1.08

Debt

Title Value Grade
Debt/EBITDA -0.9865 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 30.06 5
Yield Ebitda, % 3.69 1
Yield EPS, % -16.09 0
Total: 2.4

Institutions Volume Share, %
Anson Funds Management LP 185127 0.57
Blackrock Inc. 25018 0.08
Kellett Schaffner Wealth Advisors LLC 19060 0.06
Citadel Advisors Llc 13818 0.04
Zhang Financial LLC 13770 0.04
Virtu Financial LLC 12289 0.04
Vanguard Group Inc 10911 0.03
Two Sigma Investments, LP 10726 0.03
UBS Group AG 5615 0.02
Tower Research Capital LLC (TRC) 2447 0.01



Head Job title Payment Year of birth
Mr. John R. Beaver President, CEO & Director 377.53k 1961 (64 years)
Ms. Jennifer Bright Chief Financial Officer 355.98k 1972 (53 years)
Mr. Steven Sandor Chief Operating Officer 336.39k 1981 (44 years)
Mr. Michael C. Carroll Corporate Secretary N/A 1972 (53 years)

Address: United States, Foothill Ranch. CA -, 27042 Towne Centre Drive - open in Google maps, open in Yandex maps
Website: https://www.biolase.com